Clinical Trials
2 trialsNCT05117242 2026-04-30
Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer
Genmab
Phase 2 Active not recruiting
NCT05668650 2024-07-16
Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC
Laboratorio Elea Phoenix S.A.
Phase 3 Recruiting